A concise route to virginiamycin M2

Qi Li1, Ian B Seiple1

  • 1Department of Pharmaceutical Chemistry and Cardiovascular Reseach Institute, University of California, San Francisco, San Francisco, California 94158, United States.

Tetrahedron
|August 9, 2020
PubMed
Summary

Researchers developed a concise synthetic route to virginiamycin M2, a bacterial protein synthesis inhibitor. This efficient method offers a new way to create diverse streptogramin antibiotics for improved therapeutic potential.

Related Concept Videos